PREVALENCE OF DEPRESSION AMONG ASTHMATIC PATIENTS ADMITTED TO MEDICAL WARD DHQ TEACHING HOSPITAL BANNU
Main Article Content
Keywords
Asthma, Depression, Prevalence, Mental Health, PHQ-9, Bannu.
Abstract
Introduction: Asthma is a chronic respiratory disease that significantly affects patients’ quality of life. Psychological comorbidities, particularly depression, are increasingly recognized as important factors influencing asthma outcomes.
Objective: To determine the prevalence of depression among asthmatic patients admitted to the medical ward of DHQ Teaching Hospital Bannu.
Materials and Method: The descriptive cross-sectional study selected was carried out from June 2024 and December 2024. The sample was collected with 150 adult asthmatic patients in a consecutive method. Depression was measured in terms of the PHQ-9 scale. Demographics, asthma control, and the rate of exacerbation data were attained through data collection and analyzed using SPSS version 25.
Results: Depression was found in 60.7 percent of 150 patients. High levels of moderate to severe depression were found more commonly in patients who had poorly vice-controlled asthma with frequent exacerbations. Depressive symptoms were increased in female patients than in men.
Conclusion: Depression is highly prevalent among asthmatic patients and is associated with poor asthma control. Routine mental health screening is recommended.
References
2- Lin P, Li X, Liang Z, Wang T. Association between depression and mortality in persons with asthma: a population-based cohort study. Allergy, Asthma & Clinical Immunology. 2022 Apr 1;18(1):29.
3- Licari A, Castagnoli R, Ciprandi R, Brambilla I, Guasti E, Marseglia GL, Ciprandi G. Anxiety and depression in adolescents with asthma: a study in clinical practice. Acta Bio Medica: Atenei Parmensis. 2022 Mar 14;93(1):e2022021.
4- Homętowska H, Klekowski J, Świątoniowska-Lonc N, Jankowska-Polańska B, Chabowski M. Fatigue, depression, and anxiety in patients with COPD, asthma and asthma-COPD overlap. Journal of Clinical Medicine. 2022 Dec 16;11(24):7466.
5- Bedolla-Barajas M, Morales-Romero J, Fonseca-López JC, Pulido-Guillén NA, Larenas-Linnemann D, Hernández-Colín DD. Anxiety and depression in adult patients with asthma: the role of asthma control, obesity and allergic sensitization. Journal of Asthma. 2021 Aug 3;58(8):1058-66.
6- de Boer GM, Houweling L, Hendriks RW, Vercoulen JH, Tramper-Stranders GA, Braunstahl GJ. Asthma patients experience increased symptoms of anxiety, depression and fear during the COVID-19 pandemic. Chronic Respiratory Disease. 2021 Jun 30;18:14799731211029658.
7- Lotfata A, Moosazadeh M, Helbich M, Hoseini B. Socioeconomic and environmental determinants of asthma prevalence: a cross-sectional study at the US County level using geographically weighted random forests. International Journal of Health Geographics. 2023 Aug 10;22(1):18.
8- Patella V, Pelaia C, Zunno R, Pelaia G. Biologicals decrease psychological distress, anxiety and depression in severe asthma, despite Covid-19 pandemic. Respiratory Medicine. 2022 Aug 1;200:106916.
9- Sheha DS, Abdel-Rehim AS, Abdel-Latif OM, Abdelkader MA, Raafat RH, Sallam SA, Mostafa NS. Level of asthma control and mental health of asthma patients during lockdown for COVID-19: a cross-sectional survey. The Egyptian Journal of Bronchology. 2021 Dec;15:1-0.
10- Kulikova A, Lopez J, Antony A, Khan DA, Persaud D, Tiro J, Ivleva EI, Nakamura A, Patel Z, Tipton S, Lloyd T. Multivariate association of child depression and anxiety with asthma outcomes. The Journal of Allergy and Clinical Immunology: In Practice. 2021 Jun 1;9(6):2399-405.
11- Alanazi TM, Alghamdi HS, Alberreet MS, Alkewaibeen AM, Alkhalefah AM, Omair A, Al-Jahdali H, Al-Harbi A. The prevalence of sleep disturbance among asthmatic patients in a tertiary care center. Scientific Reports. 2021 Jan 28;11(1):2457.
12- Hu Z, Tian Y, Song X, Zeng F, Yang A. Associations between sarcopenia with asthmatic prevalence, lung function and comorbidity. BMC geriatrics. 2022 Aug 24;22(1):703.
13- McLoughlin RF, McDonald VM. The management of extrapulmonary comorbidities and treatable traits; obesity, physical inactivity, anxiety, and depression, in adults with asthma. Frontiers in Allergy. 2021 Sep 22;2:735030.
14- Cooley C, Park Y, Ajilore O, Leow A, Nyenhuis SM. Impact of interventions targeting anxiety and depression in adults with asthma. Journal of asthma. 2022 Feb 1;59(2):273-87.
15- Kharaba Z, Feghali E, El Husseini F, Sacre H, Abou Selwan C, Saadeh S, Hallit S, Jirjees F, AlObaidi H, Salameh P, Malaeb D. An assessment of quality of life in patients with asthma through physical, emotional, social, and occupational aspects. A cross-sectional study. Frontiers in public health. 2022 Sep 1;10:883784.
16- Fernández-De-Las-Peñas C, Torres-Macho J, Velasco-Arribas M, Arias-Navalón JA, Guijarro C, Hernández-Barrera V, Canto-Diez M. Similar prevalence of long-term post-COVID symptoms in patients with asthma: A case-control study. The Journal of Infection. 2021 May 3;83(2):237.
17- Saragondlu Lakshminarasappa D, Chandrasekaran V, Kandasamy P. Co‐morbid anxiety and depression in childhood asthma and its effect on symptom control: A cross sectional study. Pediatric pulmonology. 2021 Feb;56(2):378-83.
18- Maison N, Herbrüggen H, Schaub B, Schauberger C, Foth S, Grychtol R, Abdo M, Watz H, Nikolaizik W, Rabe KF, Kopp MV. Impact of imposed social isolation and use of face masks on asthma course and mental health in pediatric and adult patients with recurrent wheeze and asthma. Allergy, Asthma & Clinical Immunology. 2021 Sep 16;17(1):93.
19- Gaffin JM, Castro M, Bacharier LB, Fuhlbrigge AL. The role of comorbidities in difficult-to-control asthma in adults and children. The Journal of Allergy and Clinical Immunology: In Practice. 2022 Feb 1;10(2):397-408.